tirzepatide vs semaglutide weight loss difference and key differences, results (2026) Tirzepatide vs. Semaglutide: Which GLP-1

Patient stories on the Gala GLP-1 platform represent individual experiences and do not predict similar results for other patients

Eating smaller meals, avoiding fatty foods and ultraprocessed foods, and staying hydrated can also help

In clinical trial follow-ups, most participants began regaining weight within the first 3 months after stopping GLP-1 therapy

We've covered the eligibility criteria in detail in our guide to NHS eligibility for Mounjaro and Wegovy including what to expect from the referral process and how it compares with going private

Approximately 70 percent of adults in the US struggle with being overweight or obese